Prostate Cancer Proactive Healthcare Steps March 17, 2023 Author: Geoff McLennan, prostate cancer patient and advocate Every January since 1951 the American Cancer Society (ACS) has published an annual report about... Continue Reading
Expanding access to PARP inhibitors in prostate cancer treatment March 14, 2023 Last month, Myriad attended the 2023 ASCO Genitourinary Cancers Symposium (ASCO GU) to connect with researchers and doctors around emergent and controversial a... Continue Reading
Personalized Prostate Cancer Treatment: The Role of the Prolaris® Test March 10, 2023 Prostate cancer is a common cancer affecting men, and historically the most common approach to treatment would be either surgery or radiation therapy. However,... Continue Reading